These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 21959279)

  • 1. Paul Brown. Interview by Asher Mullard.
    Brown P
    Nat Rev Drug Discov; 2011 Sep; 10(10):726. PubMed ID: 21959279
    [No Abstract]   [Full Text] [Related]  

  • 2. DNA patent decision leaves questions for diagnostics.
    Harrison C
    Nat Rev Drug Discov; 2011 Aug; 10(9):650-1. PubMed ID: 21878971
    [No Abstract]   [Full Text] [Related]  

  • 3. The balancing act.
    Nat Rev Drug Discov; 2003 Sep; 2(9):683. PubMed ID: 12953693
    [No Abstract]   [Full Text] [Related]  

  • 4. The Critical Path Institute's approach to precompetitive sharing and advancing regulatory science.
    Woosley RL; Myers RT; Goodsaid F
    Clin Pharmacol Ther; 2010 May; 87(5):530-3. PubMed ID: 20407457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends in breakthrough therapy designation.
    Chizkov RR; Million RP
    Nat Rev Drug Discov; 2015 Sep; 14(9):597-8. PubMed ID: 26272191
    [No Abstract]   [Full Text] [Related]  

  • 6. Charles Hugh-Jones. Interview by Asher Mullard.
    Hugh-Jones C
    Nat Rev Drug Discov; 2013 Dec; 12(12):900. PubMed ID: 24287774
    [No Abstract]   [Full Text] [Related]  

  • 7. Examining Manufacturing Readiness for Breakthrough Drug Development.
    Dye E; Sturgess A; Maheshwari G; May K; Ruegger C; Ramesh U; Tan H; Cockerill K; Groskoph J; Lacana E; Lee S; Miksinski SP
    AAPS PharmSciTech; 2016 Jun; 17(3):529-38. PubMed ID: 26608693
    [No Abstract]   [Full Text] [Related]  

  • 8. Paul Stoffels. Interview by Asher Mullard.
    Stoffels P
    Nat Rev Drug Discov; 2013 Apr; 12(4):258. PubMed ID: 23535929
    [No Abstract]   [Full Text] [Related]  

  • 9. Drugs and biologics in pregnancy and breastfeeding: FDA in the 21st century.
    Kweder SL
    Birth Defects Res A Clin Mol Teratol; 2008 Sep; 82(9):605-9. PubMed ID: 18704917
    [No Abstract]   [Full Text] [Related]  

  • 10. An audience with... Gregory Lip. Interview by Asher Mullard.
    Lip G
    Nat Rev Drug Discov; 2012 Jun; 11(6):434. PubMed ID: 22653207
    [No Abstract]   [Full Text] [Related]  

  • 11. Drug industry, FDA try to stay ahead of cargo thieves.
    Traynor K
    Am J Health Syst Pharm; 2011 Jul; 68(13):1182, 1192. PubMed ID: 21690421
    [No Abstract]   [Full Text] [Related]  

  • 12. Drugs are for beauty too.
    Nature; 2003 Aug; 424(6952):981. PubMed ID: 12944925
    [No Abstract]   [Full Text] [Related]  

  • 13. An audience with... Susan Desmond-Hellmann. Interview by... Asher Mullard.
    Desmond-Hellmann S
    Nat Rev Drug Discov; 2011 Mar; 10(3):170. PubMed ID: 21358729
    [No Abstract]   [Full Text] [Related]  

  • 14. Is it possible for FDA regulatory scientists and industry scientists to work together?
    Woosley RL
    Clin Pharmacol Ther; 2012 Mar; 91(3):390-2. PubMed ID: 22343817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Janet Woodcock discusses the FDA and the drug development process. Interview by Christopher Watson.
    Woodcock J
    Drug Discov Today; 2004 Jul; 9(13):548-50. PubMed ID: 15203087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time for a medical.
    Nature; 2007 May; 447(7144):507-8. PubMed ID: 17538577
    [No Abstract]   [Full Text] [Related]  

  • 17. Joe selby. Interview by Asher Mullard.
    Selby J
    Nat Rev Drug Discov; 2011 Aug; 10(9):652. PubMed ID: 21878972
    [No Abstract]   [Full Text] [Related]  

  • 18. Richard Bergström. Interview by Asher Mullard.
    Bergström R
    Nat Rev Drug Discov; 2011 Jun; 10(6):408. PubMed ID: 21629284
    [No Abstract]   [Full Text] [Related]  

  • 19. Garry Neil. Interview by Asher Mullard.
    Neil G
    Nat Rev Drug Discov; 2012 Nov; 11(11):826. PubMed ID: 23123934
    [No Abstract]   [Full Text] [Related]  

  • 20. The right to a trial: Should dying patients have access to experimental drugs?
    Groopman J
    New Yorker; 2006 Dec; ():40-7. PubMed ID: 17176539
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.